Kehwar Than S, Das Indra J
Department of Radiation Oncology, Northwest Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
J Clin Med. 2025 Jul 26;14(15):5291. doi: 10.3390/jcm14155291.
The aim of this study was to evaluate the impact of inhomogeneity correction (IC) of dose distribution on the dosimetric and radiobiological efficacy of radiation treatment for heterotopic ossification (HO). This study involved a retrospective analysis of 21 patients treated using a homogeneous dose distribution plan for hip prophylactic HO. These IC-off plans were evaluated against an IC-on dose distribution plan. Dosimetric and corresponding radiobiological parameters (gEUD, LQ-EUD, LQ, EQD2 for α/β = 3 and 10 Gy) were calculated. These parameters were compared for both treatment plans. Additionally, Monte Carlo simulations were performed using mean and standard deviation values from baseline data to generate 10,000 synthetic datasets, allowing for robust statistical modeling of variability in dose distributions and biological outcomes. The homogeneous (IC-off) plans demonstrated overestimation of dose conformity and uniformity, reflected in lower HI values (0.10 ± 0.05 vs. 0.18 ± 0.05) and higher D-D coverage. Radiobiologically, these plans yielded higher gEUD (7.02 Gy vs. 6.80 Gy) and EQD2 values across all α/β scenarios (e.g., EQD2 = 14.07 Gy vs. 13.35 Gy), with statistically significant differences ( < 0.001). Although IC-on plans demonstrated steeper dose gradients (higher GIs), this came at the expense of internal dose variability and potentially compromised biological effectiveness. Our results suggest that plans without IC deliver suboptimal biological effectiveness if continued preferentially in routine HO prophylaxis. With advanced radiation dose calculation algorithms available in all centers, inhomogeneity-corrected doses warrant prospective validation.
本研究的目的是评估剂量分布的不均匀性校正(IC)对异位骨化(HO)放射治疗的剂量学和放射生物学疗效的影响。本研究对21例采用髋关节预防性HO均匀剂量分布计划治疗的患者进行了回顾性分析。将这些未进行IC的计划与进行了IC的剂量分布计划进行评估。计算了剂量学和相应的放射生物学参数(等效均匀剂量、线性二次等效均匀剂量、线性二次模型参数、α/β = 3和10 Gy时的等效剂量2)。对两种治疗计划的这些参数进行了比较。此外,使用基线数据的均值和标准差进行蒙特卡罗模拟,生成10000个合成数据集,以便对剂量分布和生物学结果的变异性进行稳健的统计建模。均匀(未进行IC)计划显示出对剂量适形性和均匀性的高估,表现为较低的高剂量指数值(0.10±0.05对0.18±0.05)和较高的D-D覆盖率。从放射生物学角度来看,这些计划在所有α/β情况下产生了更高的等效均匀剂量(7.02 Gy对6.80 Gy)和等效剂量2值(例如,等效剂量2 = 14.07 Gy对13.35 Gy),具有统计学显著差异(<0.001)。尽管进行了IC的计划显示出更陡的剂量梯度(更高的梯度指数),但这是以内部剂量变异性为代价的,并且可能损害生物学有效性。我们的结果表明,如果在常规HO预防中继续优先使用未进行IC的计划,其生物学有效性将次优。鉴于所有中心都有先进的放射剂量计算算法,不均匀性校正剂量值得进行前瞻性验证。